Crossmark

Putting down the phone: the obsolescence of transtelephonic monitoring for pacemaker follow-up

Crossref DOI link: https://doi.org/10.1007/s10840-018-0478-0

Published Online: 2018-10-23

Published Print: 2019-03

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Shabtaie, Samuel A.

Sugrue, Alan

Tan, Nicholas Y.

Asirvatham, Samuel

Hayes, David L.
License Information

Text and Data Mining valid from 2018-10-23
More Information

Article History

Received: 22 August 2018

Accepted: 16 October 2018

First Online: 23 October 2018

Compliance with ethical standards

:

: Drs. Samuel Shabtaie, Alan Sugrue, and Nicholas Tan have no conflicts of interest to disclose. Dr. Samuel Asirvatham has received compensation for services from Aegis Medial, ATP, Nevro, Sanovas, Sorin Group, and FocusStart, LLC. He has been a speaker for Abiomed, AtriCure, Inc., Biotronik, Boston Scientific Corp., Medtronic, Inc., Medtelligence, Spectranetics Corporation, St. Jude Medical, Sanofi Aventis, Wolters Kluver, Elsevier, and Zoll Medical Corporation. He has received royalties from Nevro and Aegis Medial. Dr. David Hayes has served as a speaker for Medtronic, Boston Scientific, Biotronik, LivaNova. He has served on research oversight committee from Abbott Medical. He has received royalties from UpToDate, Wiley, and Cardiotext.

: This study was approved by the institutional review board at the Mayo Clinic (Rochester, MN).